STateshimaMD Profile Banner
Satoshi Tateshima, MD, DMSc Profile
Satoshi Tateshima, MD, DMSc

@STateshimaMD

Followers
4K
Following
3K
Media
174
Statuses
534

Professor UCLA Interventional Neuroradiology, CNS Endovascular Surgery. Inventor, Marathon Runner, Pilot. A samurai with wings. Tweets my own, ≠medical advice

Los Angeles, CA
Joined September 2020
Don't wanna be here? Send us removal request.
@STateshimaMD
Satoshi Tateshima, MD, DMSc
3 days
SAH case with no aneurysm. The key? Not a positive finding - a negative one. After proper angling & longer injection, proximal PICA showed up. Distal portion occluded from dissection. Treated with PAO. Patient did well with partial Wallenberg. Always look for what's not there.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
5
62
@STateshimaMD
Satoshi Tateshima, MD, DMSc
10 days
Rare Case: Cognard Type V dAVF causing progressive myelopathy. Posterior fossa dAVF draining into spinal veins. Cured with transvenous embolization by drilling through occluded jugular bulb. Don’t forget cranial dAVFs in unexplained cord syndromes.
Tweet media one
Tweet media two
3
8
59
@STateshimaMD
Satoshi Tateshima, MD, DMSc
1 month
Our in-vitro study confirms what many operators intuitively feel in the angio suite: Stiffer microguidewires significantly improve catheter deliverability through tortuous anatomy. Less wire kickback & lower pushing force.
Tweet card summary image
journals.sagepub.com
Background Effective catheter navigation and trackability are crucial in neuroendovascular procedures, particularly through tortuous vessels where catheter kick...
0
2
23
@STateshimaMD
Satoshi Tateshima, MD, DMSc
2 months
Challenging cavernous dural fistula: no IPS access, tortuous SOV/facial veins. Drilled occluded IPS w/ 0.014 wire + microcath. First entering normal cav sinus., another attempt to arterialized sinus! Complete embo cure w coil/onyx. Fluoro time <40 min. Patient back to normal!
Tweet media one
Tweet media two
5
8
53
@STateshimaMD
Satoshi Tateshima, MD, DMSc
2 months
Congratulations to our outstanding graduating fellows, Dr. Keiko Fukuda & Dr. Kate Peterson! After 2 yrs of dedication & excellence in neuro-intervention @UCLAStrokeINR, they’re ready to make their mark. No doubt their future will be bright—wishing them every success ahead!
Tweet media one
Tweet media two
0
2
22
@STateshimaMD
Satoshi Tateshima, MD, DMSc
2 months
Facial venous malformation, R side kept enlarging. An accidental MRA revealed an AVM in the R masseter shunting into the VM, raising venous pressure. Treatment strategy: .→ first AVM embolized completely. → Then direct sclerotherapy Lesson: .Hidden AVMs can drive VM growth.
Tweet media one
Tweet media two
1
5
43
@STateshimaMD
Satoshi Tateshima, MD, DMSc
2 months
RT @NYNeuroendovasc: Big thanks to Dr. @STateshimaMD from UCLA for breaking down the COGNITIVE trial. The Tigertriever isn't just a cool na….
0
2
0
@STateshimaMD
Satoshi Tateshima, MD, DMSc
3 months
Lt transverse sinus durla fistula with vein of Labbe drains adjacent to the fistula site. Comaneci assisted Labbe protection during trans-arterial embo. Also Comaneci-17 assisted catheterization to a feeder. Complete embo preserving Labbe & affected transverse sinus.
Tweet media one
Tweet media two
Tweet media three
2
5
53
@STateshimaMD
Satoshi Tateshima, MD, DMSc
3 months
Excited to share our latest work on Robotics in Neurointervention—just published in the 2025 Springer textbook Arterial Treatment of Neurological Diseases! Big thanks to Amir Molaie, Naoki Kaneko, Charles Beaman. Let’s keep pushing boundaries! #neurointervention #robotics
Tweet media one
Tweet media two
1
2
30
@STateshimaMD
Satoshi Tateshima, MD, DMSc
3 months
Happy to announce successful completion of patient enrollment in Japanese approval study for TG Dilator, a novel dual-layered stent-angioplasty device to treat intracranial atherosclerotic disease presenting with acute ischemic stroke due to large vessel occlusion.
Tweet media one
2
2
54
@STateshimaMD
Satoshi Tateshima, MD, DMSc
4 months
Did a transradial cerebral angio without knowing the patient had an aberrant right subclavian artery. Turned out to be a bovine arch and direct aortic origin of the left vertebral. Basically, a vascular version of a haunted house. Would not recommend!
Tweet media one
0
2
33
@STateshimaMD
Satoshi Tateshima, MD, DMSc
4 months
Encountered an aberrant right subclavian artery today—but instead of the usual retroesophageal course, this one passed anterior to both the trachea and esophagus. An extremely rare variant—seen in less than 5% of ARSA cases!
Tweet media one
Tweet media two
Tweet media three
0
0
33
@STateshimaMD
Satoshi Tateshima, MD, DMSc
5 months
We tracked how brain arteries change over time. ✅ Arteries lengthen & become tortuous over decades.✅ Factors such as hypertension & diabetes accelerate change.✅ Insights could refine stroke & aneurysm risk prediction. Research lead by Dr. Chien.
0
0
6
@STateshimaMD
Satoshi Tateshima, MD, DMSc
5 months
Enterprise stent showed less thrombus formation than other non-coated stents—yet the manufacturer doesn’t claim this as a feature. An overlooked benefit or intentional silence on anti-corrosive parylene coating on Enterprise? .#mdpibioengineering
Tweet media one
0
0
8
@STateshimaMD
Satoshi Tateshima, MD, DMSc
6 months
We published TG dilator stent-plasty FIM cases in JNIS last year. What happened to patients who underwent conventional angioplasty w/wo stenting instead of TG dilator stent-plasty? Here is the summary.
Tweet card summary image
jnis.bmj.com
Background Intracranial atherosclerotic disease (ICAD) significantly contributes to ischemic stroke, especially among Asian populations. Large vessel occlusion (LVO) due to underlying ICAD accounts...
1
1
6
@STateshimaMD
Satoshi Tateshima, MD, DMSc
6 months
SLICE interview on a new stroke treatment catheter.
Tweet media one
0
0
6
@STateshimaMD
Satoshi Tateshima, MD, DMSc
6 months
Rapid Medical enrolls the first patient in COGNITIVE Study, the first to examine thrombectomy's impact on cognitive function. TIGERTRIEVER’s unique design may help preserve cognition.
Tweet card summary image
businesswire.com
Rapid Medical™ enrolls in the first study of the cognitive benefits of thrombectomy for ischemic stroke-enabled by TIGERTRIEVER’s active technology
0
0
4